Examining Differences in HPV Awareness and Knowledge and HPV Vaccine Awareness and Acceptability Between U.S. Hispanic and Island Puerto Rican Women

Overview

Journal J Health Dispar Res Pract

Date 2018 Jan 16

PMID 29333340

Citations 1

Authors

Daisy Y Morales-Campos

Robin C Vanderpool

Affiliations

Soon will be listed here.

Abstract

Background: In 2015, only 42% of Puerto Rican (PR) girls aged 13-17 and 44% of U.S. Hispanic girls aged 13-17 were vaccinated with all three Human Papillomavirus (HPV) vaccine doses; These percentages were far lower than the Healthy People 2020 goal of 80% of girls aged 13-15 the goal of 80%. The purpose of this study was to examine potential differences in HPV awareness and knowledge and HPV vaccine awareness and acceptability between a population-based sample of U.S. Hispanic and island Puerto Rican women.

Methods: We restricted our analyses to female respondents from the Health Information National Trends Survey (HINTS) 2007 (n=375; U.S. Hispanic) and HINTS Puerto Rico 2009 (n=417; PR). Using the Wald chi-square test, we assessed if there were significant differences in HPV awareness and knowledge and HPV vaccine awareness and acceptability between U.S. Hispanic and island PR women. We then utilized logistic or multinomial regression to control for covariates on significant outcomes.

Results: Both groups of Hispanic women were highly knowledgeable that HPV causes cancer (89.2% in both samples) and that HPV is a sexually transmitted infection (78.1% [U.S. Hispanics] and 84.7% [PR]). Less than 10% of both groups recognized that HPV can clear on its own without treatment. Island PR women had significantly higher HPV vaccine awareness (66.9% vs. 61.0%; Wald X F(1, 97) = 16.03, p < .001) and were more accepting of the HPV vaccine for a real or hypothetical daughter, compared to U.S. Hispanic women (74.8% vs. 56.1%; Wald X F(2, 96) = 7.18, p < .001). However, after controlling for sociodemographic variables and survey group, there was no longer a difference between the two groups of women and HPV vaccine awareness (AOR = .53; 95% CI = .23, 1.24). Moreover, after controlled analysis, island PR women were significantly less likely to have their hypothetical daughter get the HPV vaccine, compared to U.S. Hispanic women (AOR = 0.26; 95% CI = .08, .81).

Conclusions: Future research focused on factors contributing to differences and similarities in HPV knowledge and awareness and HPV vaccine awareness and acceptability between these two groups of Hispanic women is warranted. Findings may assist in developing health education programs and media to promote HPV vaccination among both groups.

Citing Articles

Human papillomavirus awareness among foreign- and US-born Hispanics, United States, 2017-2018.

Escobar B, Amboree T, Sonawane K, Deshmukh A, McGee L, Rodriguez A Prev Med Rep. 2021; 22:101379.

PMID: 33996392 PMC: 8102157. DOI: 10.1016/j.pmedr.2021.101379.

References

Tortolero-Luna G, Finney Rutten L, Hesse B, Davis T, Kornfeld J, Sanchez M . Health and cancer information seeking practices and preferences in Puerto Rico: creating an evidence base for cancer communication efforts. J Health Commun. 2010; 15 Suppl 3:30-45. DOI: 10.1080/10810730.2010.522698. View

Dempsey A, Zimet G, Davis R, Koutsky L . Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics. 2006; 117(5):1486-93. DOI: 10.1542/peds.2005-1381. View

Monnat S, Wallington S . Is there an association between maternal pap test use and adolescent human papillomavirus vaccination?. J Adolesc Health. 2013; 52(2):212-8. PMC: 4130478. DOI: 10.1016/j.jadohealth.2012.05.015. View

Soto-Salgado M, Suarez E, Calo W, Cruz-Correa M, Figueroa-Valles N, Ortiz A . Incidence and mortality rates for colorectal cancer in Puerto Rico and among Hispanics, non-Hispanic whites, and non-Hispanic blacks in the United States, 1998-2002. Cancer. 2009; 115(13):3016-23. PMC: 4136810. DOI: 10.1002/cncr.24340. View

Fazekas K, Brewer N, Smith J . HPV vaccine acceptability in a rural Southern area. J Womens Health (Larchmt). 2008; 17(4):539-48. DOI: 10.1089/jwh.2007.0489. View

Colon-Lopez V, Quinones V, Del Toro-Mejias L, Conde-Toro A, Serra-Rivera M, Martinez T . HPV Awareness and Vaccine Willingness Among Dominican Immigrant Parents Attending a Federal Qualified Health Clinic in Puerto Rico. J Immigr Minor Health. 2014; 17(4):1086-90. PMC: 4308559. DOI: 10.1007/s10903-014-0067-y. View

Reagan-Steiner S, Yankey D, Jeyarajah J, Elam-Evans L, Singleton J, Curtis C . National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years--United States, 2014. MMWR Morb Mortal Wkly Rep. 2015; 64(29):784-92. PMC: 4584833. DOI: 10.15585/mmwr.mm6429a3. View

Vanslyke J, Baum J, Plaza V, Otero M, Wheeler C, Helitzer D . HPV and cervical cancer testing and prevention: knowledge, beliefs, and attitudes among Hispanic women. Qual Health Res. 2008; 18(5):584-96. DOI: 10.1177/1049732308315734. View

Hajat A, LUCAS J, Kington R . Health outcomes among Hispanic subgroups: data from the National Health Interview Survey, 1992-95. Adv Data. 2000; (310):1-14. View

10.

Ogilvie G, Remple V, Marra F, McNeil S, Naus M, Pielak K . Parental intention to have daughters receive the human papillomavirus vaccine. CMAJ. 2007; 177(12):1506-12. PMC: 2096481. DOI: 10.1503/cmaj.071022. View

11.

Ortiz A, Perez J, Otero-Dominguez Y, Garcia-Rodriguez O, Garced-Tirado S, Escalera-Maldonado F . Endometrial cancer in Puerto Rico: incidence, mortality and survival (1992-2003). BMC Cancer. 2010; 10:31. PMC: 2833143. DOI: 10.1186/1471-2407-10-31. View

12.

Kobetz E, Kornfeld J, Vanderpool R, Finney Rutten L, Parekh N, OBryan G . Knowledge of HPV among United States Hispanic women: opportunities and challenges for cancer prevention. J Health Commun. 2010; 15 Suppl 3:22-9. PMC: 3858859. DOI: 10.1080/10810730.2010.522695. View

13.

Fernandez M, Allen J, Mistry R, Kahn J . Integrating clinical, community, and policy perspectives on human papillomavirus vaccination. Annu Rev Public Health. 2009; 31:235-52. PMC: 2925431. DOI: 10.1146/annurev.publhealth.012809.103609. View

14.

Petrosky E, Bocchini Jr J, Hariri S, Chesson H, Curtis C, Saraiya M . Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2015; 64(11):300-4. PMC: 4584883. View

15.

Suarez E, Calo W, Hernandez E, Diaz E, Figueroa N, Ortiz A . Age-standardized incidence and mortality rates of oral and pharyngeal cancer in Puerto Rico and among Non-Hispanics Whites, Non-Hispanic Blacks, and Hispanics in the USA. BMC Cancer. 2009; 9:129. PMC: 2684121. DOI: 10.1186/1471-2407-9-129. View

16.

Dinh T, Rosenthal S, Doan E, Trang T, Pham V, Tran B . Attitudes of mothers in Da Nang, Vietnam toward a human papillomavirus vaccine. J Adolesc Health. 2007; 40(6):559-63. DOI: 10.1016/j.jadohealth.2007.02.003. View

17.

Kahn J, Ding L, Huang B, Zimet G, Rosenthal S, Frazier A . Mothers' intention for their daughters and themselves to receive the human papillomavirus vaccine: a national study of nurses. Pediatrics. 2009; 123(6):1439-45. DOI: 10.1542/peds.2008-1536. View

18.

Marlow L, Waller J, Wardle J . Parental attitudes to pre-pubertal HPV vaccination. Vaccine. 2007; 25(11):1945-52. DOI: 10.1016/j.vaccine.2007.01.059. View

19.

Sauvageau C, Duval B, Gilca V, Lavoie F, Ouakki M . Human papilloma virus vaccine and cervical cancer screening acceptability among adults in Quebec, Canada. BMC Public Health. 2007; 7:304. PMC: 2206027. DOI: 10.1186/1471-2458-7-304. View

20.

Chao C, Slezak J, Coleman K, Jacobsen S . Papanicolaou screening behavior in mothers and human papillomavirus vaccine uptake in adolescent girls. Am J Public Health. 2009; 99(6):1137-42. PMC: 2679804. DOI: 10.2105/AJPH.2008.147876. View